Retention in care, resource utilization, and costs for adults receiving antiretroviral therapy in Zambia: A retrospective cohort study

BMC Public Health

Volumn 14, Issue 1, 2014, Pages

  Scott, Callie A ^a,b   Iyer, Hari S ^b   Mccoy, Kelly ^a   Moyo, Crispin ^c,d   Long, Lawrence ^e   Larson, Bruce A ^a,f   Rosen, Sydney ^a,e  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b Zambia Centre for Applied Health Research and Development   (Zambia)

^c MINISTRY OF HEALTH   (Zambia)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^f BOSTON UNIVERSITY   (United States)

Author keywords

Adult; Antiretroviral therapy; Costs; HIV AIDS; Outcomes; Resource limited setting; Zambia

Indexed keywords

ADENINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; PHOSPHONIC ACID DERIVATIVE; TENOFOVIR;

ADULT; AMBULATORY CARE; ANALOGS AND DERIVATIVES; CD4 LYMPHOCYTE COUNT; ECONOMICS; FEMALE; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HIV INFECTIONS; HUMAN; MALE; OUTPATIENT DEPARTMENT; PATIENT DROPOUTS; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; ZAMBIA;

ADENINE; ADULT; AMBULATORY CARE FACILITIES; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; DELIVERY OF HEALTH CARE; FEMALE; GUIDELINE ADHERENCE; HEALTH CARE COSTS; HEALTH RESOURCES; HIV INFECTIONS; HUMANS; MALE; OFFICE VISITS; ORGANOPHOSPHONATES; PATIENT DROPOUTS; RETROSPECTIVE STUDIES; ZAMBIA;

EID: 84899115068     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-14-296     Document Type: Article

References (17)

1. Zambia HIV and AIDS estimates. UNAIDS, [ http://www.unaids.org/en/ regionscountries/countries/zambia/ ]
2. Zambia country report: Monitoring the declaration of commitment on HIV and AIDS and the universal access, Biennial report. Government of the Republic of Zambia, Ministry of Health and the National AIDS Council, [ http://www.unaids.org/en/dataanalysis/knowyourresponse/countryprogressreports/ 2012countries/ce-ZM-Narrative-Report.pdf ]
3. Antiretroviral therapy for chronic HIV infection in adults and adolescents: New ART protocols. Government of the Republic of Zambia, Ministry of Health, [ http://apps.who.int/medicinedocs/documents/s19278en/s19278en.pdf ]
4. Adult and adolescent antiretroviral therapy protocols. Government of the Republic of Zambia, Ministry of Health, [ http://www.who.int/hiv/pub/guidelines/ zambia-art.pdf ]
5. Lifelong antiretroviral drugs (ARV's) for all HIV positive pregnant women in Zambia: Policy guidelines for health facilities in Zambia. Government of the Republic of Zambia, Ministry of Health, [ http://www.emtct-iatt.org/wp-content/ uploads/2013/02/Policy-guidelines-for-eMTCT-Option-B+-Zambia-2013-signed2.pdf ]
6. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. Stringer JS, Zulu I, Levy J, Stringer EM, Mwango A, Chi BH, Mtonga V, Reid S, Cantrell RA, Bulterys M, Saag MS, Marlink RG, Mwinga A, Ellerbrock TV, Sinkala M, JAMA 2006 296 7 782 793 10.1001/jama.296.7.782 16905784
7. Early clinical and programmatic outcomes with tenofovir-based antiretroviral therapy in Zambia. Chi BH, Mwango A, Giganti M, Mulenga LB, Tambatamba-Chapula B, Reid SE, Bolton-Moore C, Chintu N, Mulenga PL, Stringer EM, Sheneberger, Mwaba P, Stringer JS, J Acquir Immune Defic Syndr 2010 54 1 63 70 20009765
8. Taking ART to scale: determinants of the cost and cost-effectiveness of antiretroviral therapy in 45 clinical sites in Zambia. Marseille E, Giganti MJ, Mwango A, Chisembele-Taylor A, Mulenga L, Over M, Kahn JG, Stringer JS, PLoS One 2012 7 12 51993 10.1371/journal.pone.0051993 23284843
9. Costs of HIV/AIDS outpatient services delivered through Zambian public health facilities. Bratt JH, Torpey K, Kabaso M, Gondwe Y, Trop Med Int Health 2011 16 1 110 118 10.1111/j.1365-3156.2010.02640.x 20958891
10. Retention in care and outpatient costs for children receiving antiretroviral therapy in Zambia: a retrospective cohort analysis. Scott CA, Iyer H, Lembela Bwalya D, McCoy K, Meyer-Rath G, Moyo C, Bolton-Moore C, Larson B, Rosen S, PLoS One 2013 8 6 67910 10.1371/journal.pone.0067910 23840788
11. Recommendations of the panel on cost-effectiveness in health and medicine. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB, JAMA 1996 276 15 1253 1258 10.1001/jama.1996.03540150055031 8849754
12. Global price reporting mechanism. World Health Organization, [ http://www.who.int/hiv/amds/gprm/en/ ]
13. Medical Stores Limited, Medical Stores Limited: 2010 catalogue Lusaka, Zambia: Government of the Republic of Zambia, Ministry of Health 2010
14. World Economic Outlook Database. International Monetary Fund, [ http://www.imf.org/external/pubs/ft/weo/2012/02/weodata/index.aspx ]
15. Historical exchange rates: daily midpoint rates; 1 January 2011 to 31 December 2011. Oanda Corporation, [ http://www.oanda.com/currency/historical- rates/ ]
16. Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review. Fox MP, Rosen S, Trop Med Int Health 2010 15 Suppl 1 1 15
17. The cost of scaling-up antiretroviral treatment: a costing study in 161 representative facilities in Ethiopia, Malawi, Rwanda and Zambia [abstract THPE738]. Tagar E, Sundaram M, Condliffe K, Over M, Assefa Y, Nyemazi JP, Matatiyo B, Chilima B, Mwanamanga R, Midiani D, Moyo C, Chitah B, Batra P, Dain M, Hurley R, Kumar R, Mayer S, McCarthy T, Shear L, XIX International AIDS Conference: 22-27 July 2012 Washington, DC, USA 2012 http://pag.aids2012.org/ Abstracts.aspx?AID=19714